These studies suggest an interesting model for the onset of PAH pathogenesis in which loss of BMPRII or one of its signaling partners removes a flow-regulated brake upon SMAD2/3-driven remodeling processes by pulmonary vascular ECs. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.